SCHEMBL26335476

SCHEMBL26335476

c1ccc(-c2c(-c3ccccc3)c3cc(N(c4cccc5c4ccc4ccccc45)c4cccc5oc6ccccc6c45)ccc3c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ CYP1A1 P04798 4/20 0.33
▸ CYP1A2 P05177 4/20 0.33
▸ ABCG2 Q9UNQ0 4/20 0.33
▸ FYN P06241 1/20 0.33
▸ MAPK3 P27361 1/20 0.33
▸ AHR P35869 1/20 0.33
▸ PAX8 Q06710 1/20 0.33
▸ KDM4E B2RXH2 5/20 0.32
▸ HPGD P15428 4/20 0.32
▸ MAPT P10636 3/20 0.32
▸ TSHR P16473 3/20 0.32
▸ HSD17B10 Q99714 3/20 0.32
▸ GLA P06280 2/20 0.32
▸ HTT P42858 1/20 0.32
▸ ALDH1A1 P00352 4/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ CASP7 P55210 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26335585 0.95 TDP1 (0.35) TDP1L3MBTL1CYP1A1CYP1A2ABCG2
SCHEMBL26335407 0.93 TDP1 (0.31) TDP1L3MBTL1CA1CA2
SCHEMBL26335569 0.93 TDP1 (0.36) TDP1L3MBTL1CYP1A1CYP1A2ABCG2
SCHEMBL26337007 0.93 TDP1 (0.34) TDP1L3MBTL1CYP1A1CYP1A2ABCG2
SCHEMBL26339529 0.93 TDP1 (0.34) TDP1L3MBTL1CYP1A1CYP1A2ABCG2
SCHEMBL14134089 0.92 TDP1 (0.35) TDP1L3MBTL1CYP1A1CYP1A2ABCG2
SCHEMBL26336037 0.91 CYP1A1 (0.37) CYP1A1CYP1A2ABCG2FYNMAPK3
SCHEMBL14133826 0.90 TDP1 (0.34) TDP1L3MBTL1CYP1A1CYP1A2ABCG2
SCHEMBL26335475 0.90 DUSP3 (0.34) TDP1L3MBTL1CYP1A1CYP1A2ABCG2
SCHEMBL26335495 0.90 TDP1 (0.34) TDP1L3MBTL1CYP1A1CYP1A2ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, ELAVL1, PIEZO1 TDP1 2135/4885L3MBTL1 452/4885CYP1A1 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback